MedTrace Logo

Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)

NCT00827788 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 432

Last updated 2010-11-16

No results posted yet for this study

Summary

The purpose of this study is to determine the incidence of contrast induced nephropathy and myocardial tissue reperfusion following iso-osmolar iodixanol or ipo-osmolar iopromide administration in patients with acute myocardial infarction undergoing primary PCI.

Conditions

  • Contrast Induced Nephropathy
  • Acute Myocardial Infarction

Interventions

DRUG

Iodixanol

Iso-osmolar contrast medium (Iodixanol) will be administered during PCI

DRUG

Iopromide

Low-osmolar contrast medium (Iopromide) will be administered during PCI

Sponsors & Collaborators

  • Ospedale Le Scotte

    collaborator OTHER

  • Ospedale della Misericordia - Grosseto

    collaborator UNKNOWN

  • Ospedale San Donato

    lead OTHER

Principal Investigators

  • Leonardo Bolognese, MD, FESC · Ospedale SanDonato

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2010-04-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00827788 on ClinicalTrials.gov